Matushansky Igor 4
4 · Immuneering Corp · Filed Mar 24, 2025
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Matushansky Igor
Chief Medical Officer
Transactions
- Award
Stock Option
2025-03-21+118,000→ 118,000 totalExercise: $1.80Exp: 2035-03-21→ Class A Common Stock (118,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 17, 2026 and then in equal monthly installments over the subsequent three years, subject to the reporting person's continued employment through each applicable vesting date.